Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

BMJ · 2026 · PMC13327491 · PMID 42315290

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The reading centre determination of microvascular abnormalities and their effect on change in ETDRS best corrected visual acuity from baseline showed a trend to greater mean ETDRS best corrected visual acuity loss in SRT treated eyes with microvascular abnormalities compared with sham SRT treated eyes with microvascular abnormalities.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.